DTB Podcast

A monthly audio round-up detailing the contents of the latest issue of DTB. For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship. Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page - https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast...

https://dtbbmj.podbean.com

Eine durchschnittliche Folge dieses Podcasts dauert 12m. Bisher sind 265 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 2 days 13 hours 54 minutes

subscribe
share






recommended podcasts


episode 161: Rationalising blood tests, bempedoic acid and CV outcomes and semaglutide for obesity


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the December 2023 issue of DTB. They discuss monitoring drugs in primary care and the need to rationalise the number of blood tests undertaken (https://dt...


share









   26m
 
 

episode 160: BNF moving with the times; preventable deaths; plus an intro to pharmacogenetics


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the November 2023 issue of DTB. They discuss the history of the BNF and the announcement that the 86th edition of the BNF and the 2023–2024 edition of the...


share









 2023-10-25  20m
 
 

episode 159: Taxing ill health, and what evidence for intravenous vitamins?


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the October 2023 issue of DTB. They discuss NHS prescription charges in England and the impact they have on people with long-term ill health (https://dtb...


share









 2023-09-27  16m
 
 

episode 158: NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2023 issue of DTB. They discuss concerns over redacted data in NICE appraisal documents (https://dtb.bmj.com/content/61/9/130). They review ...


share









 2023-08-30  28m
 
 

episode 157: FeNO and asthma, low-dose aspirin and H pylori eradication, plus finerenone


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the August 2023 issue of DTB. They discuss measurement of fractional exhaled nitric oxide (FeNO) in the management of asthma (https://dtb.bmj.com/content/...


share









 2023-07-26  24m
 
 

episode 156: July 2023: Whither evidence, COI in guidelines, isotretinoin safety, SGLT2 inhibitors and Utrogestan shortage


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the July 2023 issue of DTB. They discuss evidence-based medicine, access to evidence and increasing use of press releases and social media to present evid...


share









 2023-06-28  26m
 
 

episode 155: DTB 60th anniversary podcast interview - Barbara Mintzes


In a series of podcasts to mark the 60th anniversary of DTB, we talk to some of DTB's Editorial Board members and other colleagues about their work and their involvement with DTB. In this podcast, David Phizackerley (DTB deputy editor) talks to Barba...


share









 2023-06-14  35m
 
 

episode 154: Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the June 2023 issue of DTB. They discuss new guidelines on post-exposure prophylaxisfor varicella or shingles during pregnancy (https://dtb.bmj.com/conten...


share









 2023-05-31  33m
 
 
share









 2023-05-26  33m
 
 

May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics


In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the May 2023 issue of DTB. They celebrate 60 years since DTB became independent from The Medical Letter and discuss what DTB stands for (https://dtb.bmj.c...


share









 2023-04-20  25m